The Cole Eye Institute Imaging Summit took place on Thursday, August 10, 2017 prior to the American Society of Retina Specialists (ASRS).

The is a CME symposium focusing on new advances in OCT imaging with hands-on imaging sessions. Attendees will be able to discuss current topics in tomography and imaging with a faculty of distinguished peers. Ocular imaging technology is an area of intense innovation with every year bringing better and more options to the clinic. Outcomes in vision care are best when ophthalmologists, retina specialists, and other eye care health practicioners remain informed of the latest ocular imaging capabilities. Following this course, learners will be able to better select appropriate diagnostic testing and better interpret those tests to improve patient care. Additionally, learners will be made aware of new and exciting modalities of ophthalmic imaging that can be implemented into their clinical practice.

Session Topics

-My Approach to Imaging in Diabetic Retinopathy
Barbara A. Blodi, MD

-Defining Ischemia in Retinal Vascular Disease: OCT-A or FA?
Nadia K. Waheed, MD, MPH

-How Does Imaging in RVO Guide My Clinical Decision-Making?
Aleksandra Rachitskaya, MD

-Panel Discussion: Retinal Vascular Disease Imaging
Moderator: Justis P. Ehlers, MD

Imaging In Retinal Vascular Disease

  • Imaging In Retinal Vascular Disease

    Drs. Blodi, Waheed, Rachitskaya, and Ehlers

Release Date: October 10, 2017

Expiration Date: October 10, 2018

Target Audience

The Cole Eye Institute Imaging Summit is for comprehensive ophthalmologists, retina specialists, retina fellows and healthcare providers who are interested in applying the most current, cutting-edge OCT imaging knowledge, including emerging techniques for imaging and treating retinal diseases.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the basic concept of non-confocal AO for improving ophthalmic imaging
  • Discuss novel signal processing software technologies coupled with advanced photonic imaging hardware for enhanced ophthalmic imaging applications
    Criteria for Success

    In order to receive credit, participants should watch the entire video. Statements of credit will be awarded upon successful completion of the quiz and online evaluation/claim credit form. If you have questions about this CME activity, please contact AKH Inc. at

CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Planner Disclosures

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditations

  • Nothing to Disclose

MCME Global Staff and Planners

  • Nothing to Disclose

AKH Staff and Planners

  • Nothing to Disclose

Commercial Support
This activity is supported by an educational grant from Alcon, Genentech, Regeneron Pharmaceuticals, Inc. and Santen Pharmaceutical Co., Ltd.

Faculty Disclosures

Barbara Blodi, MD

  • Nothing to disclose

Justis P. Ehlers, MD

  • Consultant: Alcon; Alimera; Carl Zeiss Meditec; Genentech; Leica; Santen; Thrombogenics
  • Contracted Research: Alcon; Genentech; Regeneron

Aleksandra Rachitskaya, MD

  • Consultant: Allergan

Nadia K. Waheed, MD

  • Consultant: Genentech; Regeneron
  • Contracted Research: Carl Zeiss Meditec; Topcon Corporation
  • Speaker Bureau: Nidek; Optovue



It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc.

Advancing Knowledge in Healthcare    mcme-logo

First Name*
Last Name*

The wide-field fluorescein angiography-guided targeted retinal photocoagulation decrease the number of intravitreal injections in RVO:


Which of the following are reasons why a retinal specialist should be able to identify diabetic retinopathy level:

Clinical trial eligibility
Insurance purposes
Patient care
All of the above

Which imaging modality is required to assess diabetic retinopathy level:

Fluorescein angiogram
Color fundus photographs
Infrared imaging